Hikal Inkomsten in het verleden

Verleden criteriumcontroles 1/6

De winst van Hikal is gedaald met een gemiddeld jaarlijks percentage van -6.5%, terwijl de winst van de Pharmaceuticals -industrie jaarlijks groeide met 15.2%. De inkomsten zijn groeide met een gemiddeld percentage van 4.7% per jaar. Het rendement op het eigen vermogen Hikal bedraagt 5.7% en de nettomarge bedraagt 3.8%.

Belangrijke informatie

-6.5%

Groei van de winst

-6.5%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie17.5%
Inkomstengroei4.7%
Rendement op eigen vermogen5.7%
Nettomarge3.8%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Earnings Tell The Story For Hikal Limited (NSE:HIKAL) As Its Stock Soars 27%

Sep 13
Earnings Tell The Story For Hikal Limited (NSE:HIKAL) As Its Stock Soars 27%

We Think Hikal Limited's (NSE:HIKAL) CEO Compensation Package Needs To Be Put Under A Microscope

Sep 11
We Think Hikal Limited's (NSE:HIKAL) CEO Compensation Package Needs To Be Put Under A Microscope

Hikal Limited's (NSE:HIKAL) Popularity With Investors Is Clear

Jun 12
Hikal Limited's (NSE:HIKAL) Popularity With Investors Is Clear

A Look At The Fair Value Of Hikal Limited (NSE:HIKAL)

Jun 03
A Look At The Fair Value Of Hikal Limited (NSE:HIKAL)

Is Hikal (NSE:HIKAL) Using Too Much Debt?

Mar 28
Is Hikal (NSE:HIKAL) Using Too Much Debt?

Hikal (NSE:HIKAL) Is Reducing Its Dividend To ₹0.60

Feb 07
Hikal (NSE:HIKAL) Is Reducing Its Dividend To ₹0.60

A Look At The Fair Value Of Hikal Limited (NSE:HIKAL)

Dec 08
A Look At The Fair Value Of Hikal Limited (NSE:HIKAL)

Increases to CEO Compensation Might Be Put On Hold For Now at Hikal Limited (NSE:HIKAL)

Sep 16
Increases to CEO Compensation Might Be Put On Hold For Now at Hikal Limited (NSE:HIKAL)

Calculating The Fair Value Of Hikal Limited (NSE:HIKAL)

Mar 18
Calculating The Fair Value Of Hikal Limited (NSE:HIKAL)

Hikal (NSE:HIKAL) Is Increasing Its Dividend To ₹1.20

Feb 16
Hikal (NSE:HIKAL) Is Increasing Its Dividend To ₹1.20

Is Hikal (NSE:HIKAL) Using Too Much Debt?

Jan 13
Is Hikal (NSE:HIKAL) Using Too Much Debt?

With EPS Growth And More, Hikal (NSE:HIKAL) Is Interesting

Jun 01
With EPS Growth And More, Hikal (NSE:HIKAL) Is Interesting

We Think Hikal (NSE:HIKAL) Can Stay On Top Of Its Debt

May 17
We Think Hikal (NSE:HIKAL) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Hikal Limited (NSE:HIKAL) Suggests It's 25% Undervalued

Mar 23
An Intrinsic Calculation For Hikal Limited (NSE:HIKAL) Suggests It's 25% Undervalued

Does Hikal Limited (NSE:HIKAL) Have A Place In Your Dividend Portfolio?

Mar 10
Does Hikal Limited (NSE:HIKAL) Have A Place In Your Dividend Portfolio?

If You Like EPS Growth Then Check Out Hikal (NSE:HIKAL) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out Hikal (NSE:HIKAL) Before It's Too Late

Be Sure To Check Out Hikal Limited (NSE:HIKAL) Before It Goes Ex-Dividend

Feb 10
Be Sure To Check Out Hikal Limited (NSE:HIKAL) Before It Goes Ex-Dividend

Is Hikal Limited's (NSE:HIKAL) Recent Stock Performance Influenced By Its Financials In Any Way?

Feb 05
Is Hikal Limited's (NSE:HIKAL) Recent Stock Performance Influenced By Its Financials In Any Way?

Opbrengsten en kosten

Hoe Hikal geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NSEI:HIKAL Opbrengsten, kosten en inkomsten (INR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2418,0346782,4390
31 Mar 2417,8466962,4860
31 Dec 2318,1587162,4340
30 Sep 2319,0848192,4530
30 Jun 2320,3239422,3890
31 Mar 2320,2307842,2520
31 Dec 2219,8016312,2300
30 Sep 2219,5448192,1280
30 Jun 2218,6471,0111,9850
31 Mar 2219,4271,6052,0820
31 Dec 2119,7281,9071,9580
30 Sep 2119,2161,8581,8380
30 Jun 2118,2451,6871,7040
31 Mar 2117,2041,3311,6810
31 Dec 2015,6701,0671,6580
30 Sep 2015,0779481,6320
30 Jun 2014,5697421,6030
31 Mar 2015,0738441,6040
31 Dec 1915,8589331,6720
30 Sep 1915,9349431,6460
30 Jun 1916,6721,1241,5950
31 Mar 1915,8961,0311,3880
31 Mar 1812,9617721,3000
31 Mar 1710,1396771,1890
31 Mar 169,2454121,1110
31 Mar 158,7054049190
31 Mar 148,2796391,1860

Kwaliteitswinsten: HIKAL heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (3.8%) HIKAL } zijn lager dan vorig jaar (4.6%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van HIKAL is de afgelopen 5 jaar met 6.5% per jaar gedaald.

Versnelling van de groei: De winstgroei HIKAL is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: HIKAL had het afgelopen jaar een negatieve winstgroei ( -28% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Pharmaceuticals ( 19.2% ).


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 5.7% ) van HIKAL wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden